ECSP077190A - Procedimiento para la prepración de 3-(4-piperidinil)-2,3,4,5-tetrahidro-1,3-benzodiazepin-2(1h)-ona - Google Patents

Procedimiento para la prepración de 3-(4-piperidinil)-2,3,4,5-tetrahidro-1,3-benzodiazepin-2(1h)-ona

Info

Publication number
ECSP077190A
ECSP077190A EC2007007190A ECSP077190A ECSP077190A EC SP077190 A ECSP077190 A EC SP077190A EC 2007007190 A EC2007007190 A EC 2007007190A EC SP077190 A ECSP077190 A EC SP077190A EC SP077190 A ECSP077190 A EC SP077190A
Authority
EC
Ecuador
Prior art keywords
benzodiazepin
piperidinil
tetrahidro
prepration
ona
Prior art date
Application number
EC2007007190A
Other languages
English (en)
Inventor
Werner Rall
Rainer Soyka
Juergen Schnaubelt
Norbert Birk
Ludwig Gutschera
Heidelore Heimbroth
Thomas Krueger
Armin Proell
Original Assignee
Boehringer Ingelheim International Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34925890&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ECSP077190(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim International Gmbh filed Critical Boehringer Ingelheim International Gmbh
Publication of ECSP077190A publication Critical patent/ECSP077190A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

Es objeto de la presente invención un procedimiento para la preparación del compuesto 3-(4-piperidinil)-2,3,4,5-tetrahidro-1,3-benzodiazepin-2(1H)-ona de la fórmula , (I)que se ha de encontrar como elemento estructural en antagonistas de CGRP que son apropiados sobre todo para la terapia oral de la migraña
EC2007007190A 2004-07-23 2007-01-22 Procedimiento para la prepración de 3-(4-piperidinil)-2,3,4,5-tetrahidro-1,3-benzodiazepin-2(1h)-ona ECSP077190A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04017424A EP1619187A1 (de) 2004-07-23 2004-07-23 Verfahren zur Herstellung von 3-(4-Piperidinyl)- 2,3,4,5-tetrahydro-1,3-benzodiazepin-2(1H)-on

Publications (1)

Publication Number Publication Date
ECSP077190A true ECSP077190A (es) 2007-03-29

Family

ID=34925890

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2007007190A ECSP077190A (es) 2004-07-23 2007-01-22 Procedimiento para la prepración de 3-(4-piperidinil)-2,3,4,5-tetrahidro-1,3-benzodiazepin-2(1h)-ona

Country Status (19)

Country Link
US (1) US7141667B2 (es)
EP (2) EP1619187A1 (es)
JP (1) JP4516118B2 (es)
KR (1) KR20070046881A (es)
CN (2) CN102040590A (es)
AR (1) AR050352A1 (es)
AU (1) AU2005266579A1 (es)
BR (1) BRPI0513468A (es)
CA (1) CA2572811C (es)
EA (1) EA011260B1 (es)
EC (1) ECSP077190A (es)
IL (1) IL180848A0 (es)
MX (1) MX2007000906A (es)
NO (1) NO20070366L (es)
NZ (1) NZ553294A (es)
TW (1) TW200613283A (es)
UA (1) UA87507C2 (es)
WO (1) WO2006010511A1 (es)
ZA (1) ZA200609919B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101146799A (zh) 2005-03-23 2008-03-19 贝林格尔·英格海姆国际有限公司 Cgrp拮抗剂、其制备方法以及其作为药物的用途
US7473778B2 (en) * 2005-12-24 2009-01-06 Boehringer Ingelheim International Gmbh 3-(4-piperidinyl)-2,3,4,5-tetrahydro-1,3-benzodiazepin-2(1H)-one
DE102007038251A1 (de) 2007-08-13 2009-02-19 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neues Herstellverfahren
US8829006B2 (en) 2007-11-22 2014-09-09 Boehringer Ingelheim International Gmbh Compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3474090A (en) * 1966-12-22 1969-10-21 American Cyanamid Co 3-aminoalkyl-1,3-benzodiazepin-2-ones
FR2518544A1 (fr) * 1981-12-22 1983-06-24 Lipha Benzodiazepines-1,3 thione-2, procede de preparation et medicament les contenant
DE19911039A1 (de) * 1999-03-12 2000-09-14 Boehringer Ingelheim Pharma Abgewandelte Aminosäureamide, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
FR2791021B1 (fr) * 1999-03-16 2001-05-11 France Design Arceau de protection pour vehicule decouvrable a toit repliable

Also Published As

Publication number Publication date
KR20070046881A (ko) 2007-05-03
US7141667B2 (en) 2006-11-28
NO20070366L (no) 2007-02-06
WO2006010511A8 (de) 2006-05-18
JP2008507484A (ja) 2008-03-13
CN102040590A (zh) 2011-05-04
TW200613283A (en) 2006-05-01
US20060019946A1 (en) 2006-01-26
EA200700041A1 (ru) 2007-08-31
BRPI0513468A (pt) 2008-05-06
MX2007000906A (es) 2007-04-13
EP1773789A1 (de) 2007-04-18
EA011260B1 (ru) 2009-02-27
CN1989114A (zh) 2007-06-27
IL180848A0 (en) 2007-07-04
EP1619187A1 (de) 2006-01-25
CA2572811C (en) 2012-09-11
UA87507C2 (en) 2009-07-27
WO2006010511A1 (de) 2006-02-02
ZA200609919B (en) 2008-07-30
AU2005266579A1 (en) 2006-02-02
AR050352A1 (es) 2006-10-18
CA2572811A1 (en) 2006-02-02
JP4516118B2 (ja) 2010-08-04
NZ553294A (en) 2009-07-31

Similar Documents

Publication Publication Date Title
NI201300043A (es) Antagonistas del receptor del cgrp de piperidinona carboxamida azaindano
ECSP088210A (es) Bencimidazoles sustituidos y métodos de preparación
GT200600084A (es) Forma cristalina beta de clorhidrato de ivabradina, su procedimiento de preparación y composiciones farmacéuticas que la contienen
SV2011003855A (es) Heteroarilos sustituidos
HN2012001265A (es) Modulares alostericos positivos de receptores mi1 de la quinolina amida
PE20152033A1 (es) Heterociclos bicicliclos como inhibidores de fgfr
NZ600430A (en) Spiro-oxindole mdm2 antagonists
ATE533762T1 (de) Chinolin- oder isochinolinsubstituierte p2x7- antagonisten
NI201100084A (es) Antagonistas del receptor de orexina de isonicotinamida.
PE20150230A1 (es) Nuevos diazaespirocicloalcanos y azaespirocicloalcanos
UY32547A (es) Piperidinas sustituidas como antagonistas de ccr3
ECSP10010582A (es) Derivados de aminodihidrotiazina como inhibidores de bace para el tratamiento de la enfermedad de alzheimer
NI200600240A (es) FORMA CRISTALINA Delta-d CLORHIDRATO DE LA IVABRADINA, SU PROCEDIMIENTO DE PREPARACIÓN, Y LAS COMPOSICIONES FARMACÉUTICAS QUE LA CONTIENEN
CR20110620A (es) Derivados de n-(hetero)aril-pirrolidina de pirazo-4-il-pirrolo[2,3-d]pirimidinas y pirrol-3-il-pirrolo[2,3-d]pirimidinas como ihnibidores de la quinasa janus
CU20100159A7 (es) Compuestos
EA201100161A1 (ru) Производные хинуклидина карбоната и их медицинские композиции
PE20141380A1 (es) Imidazopiridazinas como inhibidores de quinasa akt
ECSP066374A (es) FORMA CRISTALINA BETA-d DEL CLORHIDRATO DE IVABRADINA, SU PROCEDIMIENTO DE PREPARACIÓN Y COMPOSICIONES FARMACÉUTICAS QUE LA CONTIENEN
CU20100115A7 (es) Intermedios útiles para la preparación de derivados de carboxamida como antagonistas del receptor muscarínico
UY30534A1 (es) Derivados de 5,6-bisaril-2-piridin-carboxamida, su preparacion y su aplicacion en terapéutica como antagonistas de los receptores de urotensina ii
EA201170722A1 (ru) Лактамы в качестве ингибиторов бета-секретазы
BRPI0906522A2 (pt) Sulfonamidas como antagonistas de orexina
PH12016500989A1 (en) Crystalline form of (s)-(2-(6-chloro-7-methyl-1h-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1 -yl)(5-methoxy-2-(2h-1,2,3-triazol-2-yl)phenyl)methanone as orexin receptor antagonists
PE20110206A1 (es) Derivados dihidroindolonas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen
ECSP077190A (es) Procedimiento para la prepración de 3-(4-piperidinil)-2,3,4,5-tetrahidro-1,3-benzodiazepin-2(1h)-ona